In line with these findings, a recent study demonstrated that JNK is activated in human pancreatic cancer tissues as well as in pancreatic cancer cell lines, pointing to the possibility that K-Ras may have a role in JNK activation in pancreatic cancers [21]. This evidence concerns the gene KRAS and pancreatic neoplasm.